-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, B3UOwubGHP8aE4NUntyYDka6MzuTes0GzeWRemJVXXZcfdSuodLm8dskVJuiLAAr WPSEp8Uy/TC3fEERVGV4wA== 0001050502-07-000014.txt : 20070313 0001050502-07-000014.hdr.sgml : 20070313 20070126163052 ACCESSION NUMBER: 0001050502-07-000014 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VITRO DIAGNOSTICS INC CENTRAL INDEX KEY: 0000793171 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 841012042 STATE OF INCORPORATION: NV FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 12635 E. MONTVIEW BLVD. STREET 2: SUITE 218 CITY: AURORA STATE: CO ZIP: 80010 BUSINESS PHONE: (720) 859-4120 MAIL ADDRESS: STREET 1: 12635 E. MONTVIEW BLVD. STREET 2: SUITE 218 CITY: AURORA STATE: C0 ZIP: 80010 FORMER COMPANY: FORMER CONFORMED NAME: LABTEK INC DATE OF NAME CHANGE: 19870217 FORMER COMPANY: FORMER CONFORMED NAME: IMPERIAL MANAGEMENT INC DATE OF NAME CHANGE: 19870201 CORRESP 1 filename1.txt Vitro Diagnostics, Inc. 12635 E. Montview Blvd. Aurora, CO 80010 (720) 859-4120 Fax: (720) 859-4110 January 26, 2007 Attention: Vanessa Robertson U.S. Securities and Exchange Commission Division of Corporation Finance Mail Stop 6010 100 F Street, N.E. Washington, D.C. 20549 Re: Vitro Diagnostics, Inc./Form 8-K dated January 16, 2007 Dear Ms. Robertson: I am writing in response to your letter of January 18, 2007, and the Form 8-K filed by Vitro Diagnostics, Inc. (the "Company") on January 16, 2007. In response, please be advised that we have filed an amendment to the Form 8-K on January 24, 2007. In the amendment, we have complied with all of the comments in your letter. Specifically, the spelling of the new independent auditor for the Company was corrected to Schumacher & Associates, Inc. and all other information disclosed was identical to the original Form 8-K filed on January 16, 2007. In connection with responding to these comments, the Company hereby acknowledges that: o the Company is responsible for the adequacy and accuracy of the disclosure in the filing; o the staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and o the Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. In the event you have any further questions or comments, please feel free to contact me at the address or telephone number set forth above. Sincerely, Vitro Diagnostics, Inc. /s/ James R. Musick President, Chairman of the Board, Chief Operating and Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----